# Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

> **NCT00161798** · PHASE2 · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Tick-borne Encephalitis

## Interventions

- **BIOLOGICAL:** Tick-borne encephalitis vaccine

## Key facts

- **NCT ID:** NCT00161798
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** —
- **Final completion:** 2002-03
- **Target enrollment:** — (—)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161798, "Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00161798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*